The emerging treatment of this peptide represents a significant development in the management of the condition. Unlike existing medications, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – resulting https://tirzepatidepeptide839134.dgbloggers.com/42443411/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment